Advanced Catheter Therapies
3 known investors
Advanced Catheter Therapies develops the Pressana Occlusion Perfusion Catheter, a medical device for targeted endovascular delivery of therapeutic agents to treat peripheral arterial disease and prevent limb amputation. The device is FDA-cleared for below-the-knee use and enables localized infusion of various physician-prescribed medications to prevent restenosis after vessel modification procedures.
BiotechHealthtechMedical Devices
Founders & leadership
PJ
Paul J. FitzpatrickChief Executive Officer